A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens.
暂无分享,去创建一个
[1] Bialas Mc,et al. Adverse effects of corticosteroids. , 1998 .
[2] Frauman Ag,et al. An overview of the adverse reactions to adrenal corticosteroids. , 1996 .
[3] C. Allis,et al. Methylation of Histone H4 at Arginine 3 Facilitating Transcriptional Activation by Nuclear Hormone Receptor , 2001, Science.
[4] Richard R. Almon,et al. Fourth-Generation Model for Corticosteroid Pharmacodynamics: A Model for Methylprednisolone Effects on Receptor/Gene-Mediated Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat Liver , 1998, Journal of Pharmacokinetics and Biopharmaceutics.
[5] J. Papamatheakis,et al. Isolation and characterization of cDNA clones encoding human liver glutamate dehydrogenase: evidence for a small gene family. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[6] R. Hamman,et al. DNA sequence variation in human apolipoprotein C4 gene and its effect on plasma lipid profile. , 2000, Atherosclerosis.
[7] B. Spiegelman,et al. AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.
[8] Eric P. Hoffman,et al. The PEPR GeneChip data warehouse, and implementation of a dynamic time series query tool (SGQT) with graphical interface , 2004, Nucleic Acids Res..
[9] Jin Y. Jin,et al. Receptor/Gene-Mediated Pharmacodynamic Effects of Methylprednisolone on Phosphoenolpyruvate Carboxykinase Regulation in Rat Liver , 2004, Journal of Pharmacology and Experimental Therapeutics.
[10] Debra C DuBois,et al. The genomic response of skeletal muscle to methylprednisolone using microarrays: tailoring data mining to the structure of the pharmacogenomic time series. , 2004, Pharmacogenomics.
[11] John A Cidlowski,et al. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. , 2005, Molecular cell.
[12] N. Kaminski. Microarray analysis of idiopathic pulmonary fibrosis. , 2003, American journal of respiratory cell and molecular biology.
[13] D. DuBois,et al. Corticosteroid effects in skeletal muscle: Gene induction/receptor autoregulation , 1997, Muscle & nerve.
[14] Jin Y. Jin,et al. Pharmacogenomic responses of rat liver to methylprednisolone: An approach to mining a rich microarray time series , 2005, The AAPS Journal.
[15] R. Hanson,et al. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. , 1997, Annual review of biochemistry.
[16] B. Walker,et al. Human insulin resistance: the role of glucocorticoids , 2003, Diabetes, obesity & metabolism.
[17] S. Matsufuji,et al. Cloning and sequencing of a human cDNA encoding ornithine decarboxylase antizyme inhibitor. , 1997, Biochimica et biophysica acta.
[18] T. Jatkoe,et al. The G0/G1 switch gene 2 is a novel PPAR target gene. , 2005, The Biochemical journal.
[19] M. Takiguchi,et al. Human liver-type arginase gene: structure of the gene and analysis of the promoter region. , 1988, Nucleic acids research.
[20] J. Enghild,et al. Idiopathic Pulmonary Fibrosis , 2003 .
[21] G. Crabtree,et al. Potential basis for regulation of the coordinately expressed fibrinogen genes: homology in the 5' flanking regions. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Ramakrishnan,et al. Fifth-Generation Model for Corticosteroid Pharmacodynamics: Application to Steady-State Receptor Down-Regulation and Enzyme Induction Patterns During Seven-Day Continuous Infusion of Methylprednisolone in Rats , 2002, Journal of Pharmacokinetics and Pharmacodynamics.
[23] Y. Murakami,et al. Involvement of antizyme-like regulatory protein in polyamine-caused repression of ornithine decarboxylase in insect-derived Trichoplusia ni 5 cells. , 1997, Biochimica et biophysica acta.
[24] S. Broitman,et al. A new Kupffer cell receptor mediating plasma clearance of carcinoembryonic antigen by the rat. , 1982, The Biochemical journal.
[25] Richard R. Almon,et al. Dose-Dependence and Repeated-Dose Studies for Receptor/Gene-Mediated Pharmacodynamics of Methylprednisolone on Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat Liver , 1998, Journal of Pharmacokinetics and Biopharmaceutics.
[26] R. Farr,et al. Abnormal liver-function tests associated with long-term systemic corticosteroid use in subjects with asthma. , 1991, Journal of Allergy and Clinical Immunology.
[27] G. Mize,et al. Transcription Factor ZBP-89 Regulates the Activity of the Ornithine Decarboxylase Promoter* , 1998, The Journal of Biological Chemistry.
[28] D. Moore,et al. An Orphan Nuclear Hormone Receptor That Lacks a DNA Binding Domain and Heterodimerizes with Other Receptors , 1996, Science.
[29] D. DuBois,et al. Pharmacokinetic/Pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a Receptor/Gene-mediated mechanism. , 1999, The Journal of pharmacology and experimental therapeutics.
[30] Y. Kanai,et al. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver , 1998, FEBS letters.
[31] Debra C DuBois,et al. Corticosteroid-regulated genes in rat kidney: mining time series array data. , 2005, American journal of physiology. Endocrinology and metabolism.
[32] L. Lőcsey,et al. Dyslipidaemia and hyperlipidaemia following renal transplantation , 2006, International Urology and Nephrology.
[33] N. Friedman,et al. Statistical methods for analyzing gene expression data for cancer research. , 2002, Ernst Schering Research Foundation workshop.
[34] Sugden Mc,et al. Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia. , 2002 .
[35] Debra C DuBois,et al. Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats. , 2002, The Journal of pharmacology and experimental therapeutics.
[36] A. Willis,et al. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q , 1994, The Journal of experimental medicine.
[37] D. Granner,et al. The genes of hepatic glucose metabolism. , 1990, The Journal of biological chemistry.
[38] K. Reid,et al. Localization of the gene cluster encoding the A, B, and C chains of human C1q to 1p34.1–1p36.3 , 2004, Immunogenetics.
[39] Jorge R. Oksenberg,et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.
[40] D. Comings,et al. Sequence of human tryptophan 2,3-dioxygenase (TDO2): presence of a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat. , 1995, Genomics.